DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactOrders & Deals

Panacea Biotec Limited — Bagging/Receiving of orders/contracts

NSE 1 hr ago·5 Aug 2026, 4:44 am

Panacea Biotec

Panacea Biotec has announced that the company has received new orders or contracts. The company has informed the stock exchanges about this development, which generally signals a positive step for its business.

For investors, such news is typically viewed favorably as it indicates growth in the company's order book. This can be a sign of strong demand for its products and services, which may lead to improved revenue streams in the near future.

Investors should watch for further details regarding the nature of these orders and their expected financial impact. This information will help in assessing the long-term growth potential of the company.